Who owns LIXTE BIOTECHNOLOGY HOLDINGS?

Tip: Access positions for across all investors

Analyze quarterly positions in Lixte Biotechnology Holdings with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Lixte Biotechnology Holdings stock

Who bought or sold LIXTE BIOTECHNOLOGY HOLDINGS this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Scotia Capital 283k $869k 9% Mar 2026
 View chart
Renaissance Technologies 108k $423k 47% Dec 2025
 View chart
Vanguard Group 75k $295k 54% Dec 2025
 View chart
Federation des caisses Desjardins du Quebec 65k $198k -31% Mar 2026
 View chart
Geode Capital Management 59k $181k 13% Mar 2026
 View chart
Citadel Advisors 57k $174k 301% Mar 2026
 View chart
Vanguard Capital Management 50k $152k 100% Mar 2026
 View chart
Vanguard Fiduciary Trust 35k $108k 100% Mar 2026
 View chart
Ethos Financial Group 25k $76k 0% Mar 2026
 View chart
State Street Corporation 17k $68k 0% Dec 2025
 View chart
XTX Topco 15k $57k 100% Dec 2025
 View chart
Atlas Legacy Advisors 14k $42k 0% Mar 2026
 View chart
Hrt Financial 11k $34k 100% Mar 2026
 View chart
SBI Securities 190.00 $582.996000 0% Mar 2026
 View chart

Who sold out of Lixte Biotechnology Holdings?

Fund or Company Name Date Sold Shares Held Valued At
DRW Holdings Dec 2025 54k $213k
Two Sigma Investments Dec 2025 15k $60k
Axxcess Wealth Management Dec 2025 14k $54k
Advisor Group Holdings Sep 2025 3.2k $16k
UBS Group Dec 2025 756.00 $3.0k
Tower Research Capital Sep 2025 452.00 $2.3k